Rashtriya Chemicals Fined ₹10.62 Lakh by BSE, NSE for Board Compliance Issue
Rashtriya Chemicals and Fertilizers Limited has been levied a total fine of ₹0.1062 crore (₹10.62 lakh) by the Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE).
Reader Takeaway: Fines totaling ₹10.62 lakh for compliance lapse; waiver application is underway.
What just happened
The company received fines from both BSE and NSE on May 27, 2026. The total penalty amounts to ₹0.0531 crore (₹5.31 lakh) from each exchange, summing up to ₹0.1062 crore (₹10.62 lakh).
Why this matters
This fine stems from non-compliance with Regulation 17(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which governs the composition of the Board of Directors. While the financial impact is relatively small, adherence to board composition rules is crucial for corporate governance.
The backstory
The non-compliance relates to the company's board composition as of the quarter ended March 31, 2026. SEBI regulations mandate specific requirements for the structure and makeup of a listed company's board.
What changes now
Rashtriya Chemicals and Fertilizers Limited is currently in the process of applying for a waiver of these fines from both stock exchanges. The outcome of this application will determine the final financial impact on the company.
Risks to watch
Investors should monitor the progress of the waiver application. Any failure to secure a waiver or address the underlying compliance issue could lead to further regulatory scrutiny or potential recurrence.
Peer comparison
While specific peer data on recent regulatory fines for similar compliance issues is not provided, adherence to SEBI's LODR regulations is a standard expectation across the listed fertilizer sector.
Context metrics (time-bound)
The fines were imposed by BSE and NSE on May 27, 2026, for non-compliance identified in the quarter ending March 31, 2026. The total financial impact is ₹0.1062 crore (₹10.62 lakh).
What to track next
Investors should track the company's communication regarding the waiver application status and any steps taken to ensure future compliance with board composition norms.
